Death receptors: signaling and modulation
Avi Ashkenazi;Vishva M. Dixit.
Safety and antitumor activity of recombinant soluble Apo2 ligand
Avi Ashkenazi;Roger C. Pai;Sharon Fong;Susan Leung.
Journal of Clinical Investigation (1999)
Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family *
Robert M. Pitti;Scot A. Marsters;Siegfried Ruppert;Christopher J. Donahue.
Journal of Biological Chemistry (1996)
Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors
James P. Sheridan;Scot A. Marsters;Robert M. Pitti;Austin Gurney.
Targeting death and decoy receptors of the tumour-necrosis factor superfamily
Nature Reviews Cancer (2002)
Apoptosis control by death and decoy receptors.
Avi Ashkenazi;Vishva M Dixit.
Current Opinion in Cell Biology (1999)
Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.
Frank C Kischkel;David A Lawrence;Anan Chuntharapai;Peter Schow.
Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer
Robert M. Pitti;Scot A. Marsters;David A. Lawrence;Margaret Roy.
Apo2L/TRAIL and its death and decoy receptors.
H N LeBlanc;A Ashkenazi.
Cell Death & Differentiation (2003)
Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors.
E G Peralta;A Ashkenazi;J W Winslow;D H Smith.
The EMBO Journal (1987)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: